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Abstract
Background: Antimicrobial consumption in veterinary medicine is of great importance. Increased awareness by the
public and media has led to demands for decreased use of antimicrobials in pigs. This study aimed to identify risk
factors for regular oral antimicrobial consumption in Swiss fattening pig farms, and to quantify the amount of
antimicrobial active substances administered orally to pigs at the farm level.
Results: A case–control study was performed on 99 fattening farms between May 2014 and January 2015.
Seventy-two case farms (with oral group treatment of antimicrobials in at least 50 % of pigs) and 27 control farms
(with no regular oral group treatment) were visited once during the study. Data about potential risk factors and
antimicrobial consumption were collected by questionnaire. Antimicrobial consumption was recorded and
treatment incidence (TI) was calculated for all farms over a one year period. Sulphonamides and tetracyclines
were the antimicrobials consumed in the greatest quantity. The median TI for oral antimicrobial use in the case
group was 224.7. In the control group, the median TI was 0 for oral antimicrobial use, with values ranging from 0
to 140.1. In a multivariable regression model, seven risk factors associated with regular oral antimicrobial group
treatment were identified: mixing pigs from different suppliers within the same pen, absence of a work protocol
that ensures treating of healthy pigs before sick pigs, distance to next pig farm < 500 metres, external analysis of
production parameters, no availability of dirty visitor boots, the farmer not working on other farms, and no
application of homoeopathic agents.
Conclusions: The results of this study point out the importance of increasing farmers’ awareness of good
farming practices and biosecurity. Important recommendations for decreasing oral antimicrobial consumption
identified by this study include avoiding mixing pigs from different suppliers in the same pen and strictly
handling sick pigs after healthy ones. Improvements in these areas could enhance the overall health of pigs and
thereby reduce the consumption of antimicrobials on pig farms.
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Background
The amount of antimicrobial agents used in veterinary
medicine has been an important topic for many years.
The potential risks to public health arising from the high
use of antimicrobials in animals have been discussed in
various scientific publications as well as in the media [1].
Increased public and media awareness has put increased
pressure on farmers and veterinarians to reduce anti-
microbial use. In Switzerland, the total quantity of veter-
inary antimicrobial products sold for use in all animal
categories, reached a peak in 2008. Since 2009 the sale
of antimicrobials for veterinary use has decreased. In
2013, sales of 53,384 kg of antimicrobials were registered
in Switzerland, about two-thirds of which were anti-
microbial premixes for administration in feed or water.
The total volume sold represents a reduction of 26 % in
total Swiss antimicrobial sales compared to 2008 [2].
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Although the exact proportion of antimicrobials used in
pigs in Switzerland is not known, pigs and cattle were
estimated to account for the majority of the veterinary
antimicrobial use in 2012 [3]. Swine in Switzerland have
a high health status, as the domestic Swiss swine popu-
lation is free or almost free from several important
diseases such as porcine reproductive and respiratory
syndrome and enzootic pneumonia [4]. Despite the high
health status, antimicrobial use in Switzerland is still
relatively high compared to other countries [5]. In swine
production antimicrobials are most often applied as group
therapy [6] and mostly by oral administration [7, 8]. Previ-
ous Swiss studies have reported that the greatest quan-
tities of antimicrobials used during fattening, were used
during the first two weeks of the fattening period [9]. An-
timicrobials were most frequently administered prophylac-
tically (about 80 % of total amount) [10]. However,
prophylactic antimicrobial use has not been shown to
decrease mortality, or to reduce the number of therapeutic
treatments [10]. Therefore, it could be speculated that
there is substantial potential to reduce antimicrobial usage
while maintaining a high animal health status.
High antimicrobial consumption is also a concern in
other countries. For example, Denmark has introduced a
“yellow card”scheme, which imposes restrictions on farmers
who exceed predefined levels of consumption [11]. In
Germany, a 2014 amendment to legislation introduced a
legal requirement for farmers to report antimicrobial use
and the antimicrobial usage data is stored in a central data-
base. In addition the responsible local veterinary service has
the authority to impose measures on farmers whose anti-
microbial usage exceeds defined levels [12]. In the
Netherlands an independent institution sets benchmarks
for antimicrobial usage, which are re-evaluated on a yearly
basis. Farms that exceed these benchmark levels are obliged
to decrease their consumption by implementing measures
[13]. Since the introduction of this program in 2012,
antimicrobial consumption has been reduced by 56 %
compared to consumption in 2007. This has been achieved
by a combination of compulsory and voluntary actions. The
Netherlands has set a new goal of reducing consumption in
2015 by 70 % compared to 2007 [14]. In Switzerland,
there is currently no central antimicrobial consump-
tion database that could be used to set benchmarks
for antimicrobial consumption.
The identification of risk factors for antimicrobial
group treatment in fattening farms is important for
developing on farm strategies for reducing antimicrobial
use without impairing animal health. However, only a
limited number of risk factors for high antimicrobial use
have been reported [15–17]. In a study performed in the
Netherlands, the risk factors farm system and number of
fattening pigs were found to be associated with anti-
microbial use on fattening farms [15]. Hybschmann et
al. performed a risk factor analysis in Denmark on anti-
microbial use for gastrointestinal diseases [16]. Herd
size, herd health status and herd type were identified as
risk factors [16]. Compared to these countries, herd sizes
in Switzerland are smaller and many farms produce for
specific pork distribution labels. Farms are often specia-
lised in farrowing or fattening and few produce in a
closed system. It is likely that risk factors from studies in
other countries will not be valid under these housing
and management conditions. The identification of fur-
ther risk factors would be crucial to support reduction
of antimicrobial use. For this reason we conducted a risk
factor analysis for fattening pig farms in Switzerland.
This study will be relevant to Swiss swine producers and
can serve as an example to other countries that have
small farms and good general pig health.
The aim of this case–control-study was, to identify
risk factors for regular oral antimicrobial treatment in
Swiss fattening farms, and to quantify the amount of
antimicrobials used at a farm level during a 12-month
period.
Results
Farm characteristics
A list of 437 potential participants was generated from
the Swiss Pig Health Service (SGD) database. Two
hundred and sixteen farms were excluded. Of these, 106
farms were excluded before telephone contact, when the
list was checked by SGD veterinarians having more
current knowledge about these farms, because these
farms no longer fulfilled the inclusion criteria. The other
110 farms were excluded after the first telephone inter-
view because they no longer used regular oral antimicro-
bial group treatments. Of the farms that met the
antimicrobial inclusion criteria, 50 % agreed to partici-
pate in the study (77 % in the control group, 44 % in the
case group). Reasons for not participating included: no
interest (total 66 %, control 67 %, case 66 %), farm struc-
ture (retirement, ending or already ended pig farming,
less than 30 pigs, farmer participates in the study with
his other farm) (total 32 %, control 33 %, case 31 %), and
other reasons (total 3 %, control 0 %, case 3 %). Eleven
of the 110 farms that agreed to participate were excluded
retrospectively because they raised pigs for other purposes
than fattening.
The final study sample consisted of 99 fattening farms.
Ninety-two percent of the farms were members of the
SGD. The median weight of pigs at the onset of the
fattening period was 25.5 kg (n = 97) and the median live
weight at slaughter was 109.9 kg (n = 87). Herd size
varied between 50 and 1300 pig places (median 170).
The proportion of total farm revenue represented by
swine production varied between 1-100 % (median
25 %). Seventy percent of farmers were between 41 and
Arnold et al. Porcine Health Management  (2016) 2:5 Page 2 of 9
60 years old, 14 % were younger than 41, and 16 % older
than 60. As a consequence, 68 % of farmers had more
than 24 years of experience in pig production. For most
farms, the person having the main responsibility for the
pigs was the owner of the farm (85 %). Other farms were
on a lease arrangement (10 %), partly owned and leased
(1 %), or the main responsible person was employed
(4 %). Time spent in the pig barn ranged from 0.8 to
28 h per week per 100 pig places with a median of 4.2 h
per week per 100 pig places. Daily weight gain of pigs
ranged from 675 to 1,014 gram with a median of 808.9
gram (n = 80). The median duration of the fattening
period was 102 days. Feed conversion (digestible energy
pig (DE)/kg) values ranged from 32.5 to 41.0 megajoules
DE/kg with a median of 36.0 megajoules DE/kg.
However, these data were only available for 70 farms.
Mortality rates were less than or equal to 2 % in 69 % of
the farms (0–5.5 %, median 1.6 %, n = 97).
Antimicrobial use
A total of 500 kg of active antimicrobial substance was
administered orally on the 99 study farms during the
12 months prior to the investigation. Active ingredients
used were sulphonamides (305 kg, 61 %), tetracyclines
(125 kg, 25 %), trimethoprim (42 kg, 8 %), polymyxin E
(8 kg, 2 %), amoxicillin (11 kg, 2 %), macrolides (9 kg,
2 %), and pleuromutilins (0.5 kg, 0.1 %). Five of the
twenty-seven control farmers also administered oral
antimicrobials, but they all reported treating less than
50 % of their pigs. In both case and control farms, all
oral antimicrobials were administered in feed. Results of
TI calculations for active substances used orally are
presented in Table 1. In the case group, the TI for oral
antimicrobials ranged from 29.9 to 418.1 (median 224.7,
mean 211.7, SD 101.3). The TI for the control group
ranged from 0 to 140.1 (median 0, mean 10.5, SD 29.4).
In the case group, 72 % of the farms administered oral
antimicrobials to all pigs. The remaining 28 % of case
farms orally administered antimicrobials to at least 50 %
of pigs during the 12 months prior to the investigation.
In the case group, 93 % of the farmers reported that they
administered oral antimicrobials mainly for prophylaxis.
They usually did not carry out diagnostic examinations
prior to treatment, since the treated pigs did not have
any abnormal clinical signs. The other 7 % of case farms
reported using antimicrobials orally to treat specific con-
ditions (diarrhoea, fever, respiratory symptoms, lame-
ness). Reasons for using oral antimicrobials reported by
case group farmers were (multiple answers possible, n in
parenthesis): problems occurred during previous fatten-
ing period(s) (22), too many different pig suppliers (20),
as an insurance policy (16), always used antimicrobials
(17), on recommendation (e.g. veterinarian or pig trader)
(17) or that an attempt without antimicrobials was not
successful (10). All case group farmers were asked if they
would also use antimicrobials at the beginning of the
production period if they always received pigs from the
same single supplier. Forty-four percent answered yes or
that they already had only one supplier; forty-eight
percent reported that it would probably be possible to
work without antimicrobials if they had one supplier,
and 8 % were unsure.
The analysis of antimicrobials administered as injection
was performed accordingly. The TI for antimicrobial
injections ranged between 0 and 23.3 (median 3.3, mean
5.0, SD 5.5) for the control group and between 0 and 68.5
(median 4.0, mean 5.6, SD 12.5) for the case group.
Risk factor analysis
The results of screening analyses of risk factors that
were associated with the case or control status of the
farm (p-value <0.1), are presented in Table 2. Factors
Table 1 Treatment incidence (TI = Number of animals treated daily with one animal daily dose (ADD) per 1000 pigs) of the
active substances for all oral antimicrobials used during the 12 months prior to the investigation of farms. Data are presented
for the case group (with oral group treatment of antimicrobials in at least 50 % of pigs) and the control farms (with no regular
oral group treatment)
TI case group (n = 80) TI control group (n = 30)
Min1 Max2 Median Mean SD3 Min Max Median Mean SD
Sulphonamides 0.0 258.2 101.6 100.6 82.9 0.0 93.4 0.0 4.3 18.1
Tetracyclines 0.0 365.8 0.0 35.5 61.3 0.0 13.5 0.0 0.8 3.0
Trimethoprim 0.0 129.1 34.6 43.9 46.8 0.0 46.7 0.0 1.7 9.0
Polymyxin E 0.0 196.2 0.0 6.9 27.8 0.0 41.1 0.0 2.0 8.2
Amoxicillin (penicillin) 0.0 103.0 0.0 7.8 22.6 0.0 13.3 0.0 0.8 3.0
Macrolides (tylosin) 0.0 117.2 0.0 16.0 31.3 0.0 13.5 0.0 0.8 3.0
Pleuromutilins (valnemulin) 0.0 73.2 0.0 1.0 8.6 0.0 0.0 0.0 0.0 0.0
Min1 minimum
Max2 maximum
SD3 standard deviation
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Table 2 All relevant results of the univariable analysis of risk factors (p < 0.1) for regular oral antimicrobial group treatment in case
farms (more than 50 % of pigs treated) and in control farms (no regular oral group treatment) for Swiss fattening pig farms
Description Answers % control group % case group p-value (chi2 or
fisher’s exact)
n = 27 n = 72
Label Conventional or no label 51.9 37.5 0.0427
Label 1 (straw, access to outdoor area) 25.9 33.3
Label 2 (bedding, access to outdoor area) 14.8 29.2
Label 3 = Organic 7.4 0.0
Renovation of building (pen) Yes 25.9 58.3 0.0041
No 74.1 41.7
Husbandry education Education 1 (farmer with a certification
of achievement)
33.3 33.3 0.0211
Education 2 (Apprenticeship and further
education as pig farm manager)
59.3 38.9
Others/no husbandry education 7.4 27.8
Working on other farms Yes 25.9 8.3 0.0398
No 74.1 91.7
Analysis of production parameters By farmer (program, computer, written, none) 66.7 30.6 0.0011
By others (external) 33.3 69.4
Most frequent cause of death at the onset Haemorrhagic intestinal syndrome 55.6 33.3 0.0252
Unknown cause of death 33.3 36.1
Other causes 11.1 30.6
Visitor boots available Yes, clean 33.3 43.4 0.0084
Yes, dirty 33.3 15.2
No 33.3 41.4
Production system all-in/all-out Yes 48.2 77.8 0.0043
No 51.9 22.2
Number of suppliers at the same time One supplier 51.9 19.4 0.0014
More than one supplier 48.2 80.6
Pigs originate from same supplier(s) Yes 59.3 23.6 0.0008
No 40.7 76.4
All pigs vaccinated against Lawsonia Yes 33.3 13.9 0.0287
No or unknown 66.7 86.1
Mixing pigs of different suppliers
within same pen
Yes 33.3 66.7 0.0028
No 66.7 33.3
Work sequence depending on the age From younger to older pigs 18.5 11.1 0.0115
No working order (age not considered) 55.6 30.6
All pigs having the same age 25.9 58.3
Cleaning frequency After each batch: whole barn 44.4 72.2 0.0191
After each batch: pen(s) 37.0 15.3
Less frequent 18.5 12.5
Heating of barn (before the onset) Yes 37.0 56.9 0.0775
No 63.0 43.1
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with a p-value ≥0.1 in the screening included the follow-
ing topics: health-related data (e.g. estimated disease
frequencies or if diagnostic tests had previously been
performed), biosecurity (e.g. details about pest control or
hand wash facilities), other management practices (e.g.
deworming or feeding practices), housing system (e.g.
access to outdoor facility or floor types) as well as farm
structure and demographic data (e.g. herd size, age of
the animal caretaker or if the caretaker owns the
farm or is employed).
Variables that were included in the final multivariable
logistic regression model are presented in Table 3. Seven
factors associated with regular use of antimicrobials in
feed were identified. A farmer mixing pigs from different
suppliers within the same pen had a 4 times higher odds
of being in the group with regular oral antimicrobial use
than farmers that did not mix pigs. Proximity to other
pig farms was also found to be a potential risk. The odds
of being in the case group were almost 10 times greater
among farms having a neighbouring farm within a 500
meter radius. Farmers, who did not follow a specified
work sequence that included managing healthy pigs
before sick pigs, had approximately 16 times higher odds
of being in the case group than farmers who followed such
a sequence. Farmers who did not use homoeopathic
agents had about 10 times higher odds of being in the
group with regular antimicrobial use than farmers who
used homoeopathic agents. Working on other farms had a
protective effect, as farmers who worked on other farms
were less likely to be in the case group (odds ratio = 0.05).
The analysis of performance data by the farmer (program,
computer, written, or none) was also found to be protect-
ive (odds ratio = 0.12). The presence of dirty visitor boots
on farms was protective (odds ratio = 0.06) when com-
pared to the absence of visitor boots.
Discussion
In this study risk factors for regular oral antimicrobial
use on Swiss fattening pig farms were identified and the
amount of antimicrobials used at a farm level was quan-
tified. Participation rates were 77 % for the control, and
44 % for the case groups (in total 50 %). The difference
in participation between the two groups may have been
influenced by the study design. All of the case farms
were also enrolled in an additional longitudinal study for
the FitPig project, which required at least one additional
Table 2 All relevant results of the univariable analysis of risk factors (p < 0.1) for regular oral antimicrobial group treatment in case
farms (more than 50 % of pigs treated) and in control farms (no regular oral group treatment) for Swiss fattening pig farms
(Continued)
Work sequence depending on healthy
before sick pigs
Yes 59.3 20.8 0.0002
No 40.7 79.2
Distance to the next pig farm <500 metres 25.9 56.9 0.0060
≥500 metres 74.1 43.1
Application of homoeopathic agents Yes 25.9 5.6 0.0084
No 74.1 94.4
P-values of the chi2 analysis are presented or alternatively for factors with counts ≤5 for a group, results of the fisher’s exact testing are shown
Table 3 Results of the multivariable logistic regression model for the risk factor analysis for oral antimicrobial use in Swiss fattening
pig farms
Description Answers p-value model ORb 95 % CIc
Work sequence depending on healthy before sick
pigs (Ref.a Yes)
No <0.01 16.68 3.4-81.8
Working on other farms (Ref. No) Yes <0.01 0.05 0.006-0.4
Distance to the next pig farm (Ref. ≥ 500 metres) <500 metres 0.01 9.88 1.7-57.1
Visitor boots available (Ref. No boots available) Yes, clean 0.97 1.03 0.2-4.7
Yes, dirty 0.01 0.06 0.006-0.5
Analysis of production parameters (Ref. by others (external)) By farmer (program, computer,
written, none)
0.01 0.12 0.02-0.6
Application of homoeopathic agents (Ref. Yes) No 0.02 10.49 1.4-78.8
Mixing pigs of different suppliers within the same pen
(Ref. No mixing)
Yes 0.05 4.16 1.0-17.4
aRef.: reference group
bOR: odds ratio
cCI: confidence interval
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farm visit. Therefore, more case than control farmers
elected not to participate, because the farmers consid-
ered the extra visit(s) to be too time-consuming. For this
reason voluntary participation by farmers may have
introduced a bias into this study. Having a biased sample
may have resulted in an underestimation of antimicro-
bial consumption. This bias could be stronger in the
case farms, because the participation rate was lower in
this group.
Antimicrobial use
Sulphonamides and tetracyclines accounted for the major
proportion of orally administered substances. This is in
agreement with findings reported in an earlier study
performed in Switzerland [18]. The usage patterns re-
ported in this study differ from those found in other
countries, where tetracyclines are more commonly used
than sulphonamides [13, 19, 20]. A possible explanation
could be that Swiss pig farmers were discouraged from
using certain antimicrobials, including tetracyclines, in the
past and SGD members are still discouraged from using
certain antimicrobials, including tetracyclines, without
carrying out further diagnostics. This is done to prevent
antimicrobial administration from masking of clinical
signs of economically important diseases such as enzo-
otic pneumonia or swine dysentery which are systematic-
ally monitored by the authorities or the SGD health
programme (personal communication Y. Masserey, head
of regional SGD office).
To allow a standardized comparison of usage among
farms, the TI was calculated. The TI has been used in
previous studies to describe antimicrobial use [7, 21, 22].
In this study there was a wide range of farm level TI
values. This was likely due to the definition of case and
control farms used in this study. For this reason, the TI’s
may not be representative of Swiss fattening farms and
generalizing to the population of Swiss fattening farms
should be done with caution. On the farms in this study,
there was no evidence that the control group had to
compensate for the lower use of oral antimicrobials using
a larger quantity of parenteral use of antimicrobials.
A comparison to the TI’s found in other studies was not
carried out, because methods for calculating TI’s has not
been standardized across countries and the recommended
animal daily dose (ADD) varies between countries. An
international working group is currently developing a list of
ADD’s that is valid for international use [23]. However, at
this time the list does not include all antimicrobial products
used on farms in this study. Other differences between
countries include variation in methods for estimating days
at risk and for kg of pig treated [7, 21]. In a recent study
Moreno 2014 [24] reported that different values were used
in almost all studies. Setting standard values is crucial for
enabling comparisons between countries.
Five of the twenty-seven control farms used oral anti-
microbials. Even though the TI’s on these farms were
low, there was a small number of control farms that had
higher TI values than some of the case farms. On
control farms oral administration mostly took place later
in the fattening period and for therapeutic treatment of
sick animals. These animals had a higher average weight
and therefore more active substance was required to
treat them. This could not be accounted for in the calcu-
lation of the TI used in this study, because the same
standard pig weight was used for all farms. Finally,
differences in TI may have been due to farmers adminis-
tering antimicrobials at lower than recommended dosages,
or for shorter treatment periods than recommended.
There were differences in data quality between farms
because some farmers did not report the number of
animals treated or the administered dosage. For these
reasons it was possible to calculate TI based only on
amount of active substance used, rather than calculating
daily doses used.
Risk factor analysis
In this study, seven risk factors for increased oral anti-
microbial use at the beginning of the fattening period
were identified in Swiss fattening farms. A higher risk
for oral antimicrobial use was found on farms mixing
pigs from different supplying farms within the same pen.
It is very likely that pigs from different farms were
exposed to different pathogens. Transport in combin-
ation with formation of new groups [25] can cause stress
for the animals, and can increase the risk of disease
occurrence. This first risk factor was associated with the
number of supplying farms, and whether the suppliers
changed over time. These were also identified as risk
factors in other studies [10, 26]. However, these were
not in the final multivariable model in this study. A
work sequence, in which sick animals were handled
before healthy ones, was also a risk factor for regular
antimicrobial use. This risk factor could be related to
differences in the awareness of the importance of good
management practices between case and control farms.
The difference in awareness might also explain why
other risk factors such as not working on other farms,
external analysis of production parameters and no avail-
ability of dirty visitor boots were associated with in-
creased oral antimicrobial use. Working on other farms
may support the exchange of knowledge and increase
the general awareness for good biosecurity. The factor of
dirty visitor boots being of a lower risk than no visitor
boots cannot be easily explained. It is possible that in a
retrospective study design as applied in the present
investigation, some factors in statistical analysis could
have been found by coincidence. The higher risk for
farms located in a radius of less than 500 metres to other
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pig farms could be due there being a higher probability
of pathogen transfer over short distances. This factor
was already described by van der Fels-Klerx et al. [15] as
potential risk factor. Farms administering homoeopathic
agents had a lower risk for regular antimicrobial con-
sumption. It may be possible that farmers in the control
group were looking for alternative substances to antimi-
crobials and used homoeopathic agents instead. An in-
direct association may be more likely than direct causality
for some risk factors. For example external analysis of
performance data could be interpreted as indicator for the
professional attitude of the farmers. Some of the factors
not being part of the multivariable model in this study
have been reported as risk factors in other studies. The
size of the farm [15, 16] had no significant effect in this
study. In another study performed in Switzerland, the
sanitary break (time period when no pigs are in the barn
or pen, before the next group of pig arrives), and not
consequently practicing all-in-all-out were identified as
risk factors, but were not part of the multivariable model
of this study [10].
Conclusion
In this study, risk factors for increased oral antimicrobial
use on Swiss fattening pig farms were identified. An
important recommendation to decrease oral antimicro-
bial consumption would be to avoid mixing pigs from
different suppliers in the same pen. Additionally, more
attention should be paid to the work sequence. Sick pigs
should be handled after handling healthy ones. This study
suggests that it would be important to increase the aware-
ness of the farmers of the value of good farming practices,
biosecurity and herd health. Improving the overall health
of the pigs would help to reduce the consumption of oral
antimicrobials on fattening pig farms.
Methods
Data collection
Study design
A case–control study was performed with 99 fattening
pig farms in Switzerland. Each farm was visited once.
The control group consisted of 27 and the case group of
72 participating farms. The difference in group sizes was
due to a follow-up intervention study in which only the
farms of the case group participate. The follow-up study
is a controlled field trial with the aim to reduce anti-
microbial usage in farms with routine use of oral antimi-
crobials. The sample size for our study was calculated to
detect an odds ratio of 3.5 with a power of 80 % and a
significance level of 5 %, using the software PASS 12
(Hintze, J. (2013). PASS 12. NCSS, LLC. Kaysville, Utah,
USA. www.ncss.com). The following inclusion criteria
were used to define and select case farms: oral antimicro-
bial group treatment taking place at the beginning of the
fattening period had to be administered to at least 50 % of
all pigs during the previous twelve months. The control
group included farms without routine oral group
treatment or, farms where oral antimicrobials were
administered to less than 50 % of all pigs in the last
12 months. The minimum farm size was 30 pig places.
The person mainly responsible for the pigs had to
have adequate German language skills to be able to
answer the questionnaire accurately.
Recruitment
A list of potential case and control farms was generated
from the database of the SGD, where information on
oral antimicrobial treatments was available from January
2011 to August 2014. About 60 % of the Swiss fattening
farms are members of the SGD (personal communica-
tion HP. Keller, CEO SUISAG). Farmers joining the
SGD benefit from a health programme with the main
goal of preventing the spread of economically important
diseases. The programme mainly consists of certifying
farms according to their health status and rules for pig
trading. Regular farm visits by a veterinarian are also a
key element of the programme. All farms fulfilling the
study inclusion criteria were extracted from the SGD
database. To achieve a broader representation of the
Swiss population of pig fattening farms, an additional
effort was made to recruit farmers who were not mem-
bers of the SGD. Veterinarians of the Swiss Association
of Pig Medicine were asked to identify farms fulfilling
the inclusion criteria. From the list of both groups of
farmers, case and control farms were randomly selected
until a sufficient sample size of farms, fulfilling all inclu-
sion criteria, was achieved. Initially, a letter was sent to
all farmers, informing them about the upcoming project.
Farmers were subsequently contacted by telephone, inclu-
sion criteria were verified, and they were asked to partici-
pate. All participants were recruited and visited between
May 2014 and January 2015. All visits were performed by
3 veterinarians working on the project.
Materials
Data were collected using two questionnaires. One was
sent to the farmers before the farm visit and the second
was completed during the farm visit. Questionnaires
were designed by a group of experts (pig veterinarian,
epidemiologists, and agronomist) to align with the re-
sults of former studies [10, 22]. Questionnaires included
the following topics: farm structure and details about the
farmer, performance data, housing, management, food
and water supply, health of pigs, biosecurity and anti-
microbial use. Draft questionnaires were evaluated by a
social scientist with experience in questionnaire design
and the questionnaire was pretested on 2 farms. The
results of the pre-test were not included into the final
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analysis. Questionnaires are available on request from
the authors (in German). Data on the antimicrobial
consumption within the last twelve months were ex-
tracted either from the farm inventory or the treatment
journal, prescription forms or, if these were not available,
from the veterinarian’s invoices.
Data analysis
Statistical analysis was performed using NCSS 9, NCSS,
LLC. Kaysville, Utah, USA. Descriptive statistic was
carried out for potential risk factors and antimicrobial
usage. For antimicrobial consumption, the amount of
active substance used was calculated for each substance
separately as the product of number of units (e.g. ml,
mg) administered and the weight of active ingredient per
unit (e.g. mg/ml or mg/kg). To enable a comparison of
the antimicrobial use between farms, the TI was chosen
as a measure of usage [7, 21, 22]. The TI was calculated
by dividing the amount of active substance used (mg)
through the product of: the ADD, the days at risk and
kg weight of pigs. The outcome was then multiplied by
1000. The TI is a measure of the number of animals
treated daily with one ADD per 1000 pigs [21]. Informa-
tion about the ADD for each product was extracted
from the Swiss on-line database of pharmaceutical prod-
ucts [27]. For products with a range of recommended
doses, the lowest value was used for orally administered
antimicrobials. For antimicrobials administered by injec-
tion, the highest value was used. This protocol was
based on previous studies demonstrating that oral anti-
microbials are often administered at below the recom-
mended dosage, and injections are more likely to be
administered at above the recommended dosage [7, 21].
To estimate the number of days at risk, the median
length of the fattening period was taken from the data
collected by questionnaire. The kg weight of pigs was
calculated as the total number of pigs produced in one
year multiplied with the average weight at the beginning
of fattening. Since weight was not available on all of the
study farms, the average weight at the beginning of
fattening (26.8 kg) in 2014 was obtained from one of the
main Swiss pig marketers (personal communication M.
Reich, Anicom, Switzerland).
All data were entered into NCSS 9 and checked for
plausibility and counts per group. Continuous data,
where a non-linear relationship with the outcome was
expected, were grouped into several categories. Univari-
able screening of all potential risk factors was performed
using chi-squared tests. For factors that contained less
than 5 counts per group, fisher’s exact tests were
performed. Variables with p-values < 0.1 were considered
for entry into the multivariable logistic regression model.
All potential risk factors were screened for correlation
among each other. If a high correlation between two
variables was observed (phi > 0.7), the biologically more
meaningful variable was selected for the model. The
multivariable logistic regression model was built with a
stepwise forward selection procedure. Only variables
significantly associated with being a case farm (p < 0.05)
were retained in the model. Biologically meaningful
interactions between the risk factors were tested, but
none of them was significant.
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